These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 25941060

  • 1. Long-term medical risks to the living kidney donor.
    Lam NN, Lentine KL, Levey AS, Kasiske BL, Garg AX.
    Nat Rev Nephrol; 2015 Jul; 11(7):411-9. PubMed ID: 25941060
    [Abstract] [Full Text] [Related]

  • 2. Risk of end-stage renal disease following live kidney donation.
    Muzaale AD, Massie AB, Wang MC, Montgomery RA, McBride MA, Wainright JL, Segev DL.
    JAMA; 2014 Feb 12; 311(6):579-86. PubMed ID: 24519297
    [Abstract] [Full Text] [Related]

  • 3. End-stage renal disease risk in live kidney donors: what have we learned from two recent studies?
    Lam NN, Lentine KL, Garg AX.
    Curr Opin Nephrol Hypertens; 2014 Nov 12; 23(6):592-6. PubMed ID: 25160076
    [Abstract] [Full Text] [Related]

  • 4. End-stage renal disease among living-kidney donors: single-center experience.
    Wafa EW, Refaie AF, Abbas TM, Fouda MA, Sheashaa HA, Mostafa A, Abo El Ghar MI, Ghoneim MA.
    Exp Clin Transplant; 2011 Feb 12; 9(1):14-9. PubMed ID: 21605018
    [Abstract] [Full Text] [Related]

  • 5. Understanding and Communicating Medical Risks for Living Kidney Donors: A Matter of Perspective.
    Lentine KL, Segev DL.
    J Am Soc Nephrol; 2017 Jan 12; 28(1):12-24. PubMed ID: 27591246
    [Abstract] [Full Text] [Related]

  • 6. Risks of Living Kidney Donation: Current State of Knowledge on Outcomes Important to Donors.
    Lentine KL, Lam NN, Segev DL.
    Clin J Am Soc Nephrol; 2019 Apr 05; 14(4):597-608. PubMed ID: 30858158
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Long-term Mortality Risks Among Living Kidney Donors in Korea.
    Kim Y, Yu MY, Yoo KD, Jeong CW, Kim HH, Min SI, Ha J, Choi Y, Ko AR, Yun JM, Park SM, Yang SH, Kim DK, Oh KH, Joo KW, Ahn C, Kim YS, Lee H.
    Am J Kidney Dis; 2020 Jun 05; 75(6):919-925. PubMed ID: 31866225
    [Abstract] [Full Text] [Related]

  • 10. Moving closer to understanding the risks of living kidney donation.
    Steiner RW.
    Clin Transplant; 2016 Jan 05; 30(1):10-6. PubMed ID: 26689427
    [Abstract] [Full Text] [Related]

  • 11. The Minnesota attributable risk of kidney donation (MARKD) study: a retrospective cohort study of long-term (> 50 year) outcomes after kidney donation compared to well-matched healthy controls.
    Vock DM, Helgeson ES, Mullan AF, Issa NS, Sanka S, Saiki AC, Mathson K, Chamberlain AM, Rule AD, Matas AJ.
    BMC Nephrol; 2023 May 01; 24(1):121. PubMed ID: 37127560
    [Abstract] [Full Text] [Related]

  • 12. Self-Reported Incident Hypertension and Long-Term Kidney Function in Living Kidney Donors Compared with Healthy Nondonors.
    Holscher CM, Haugen CE, Jackson KR, Garonzik Wang JM, Waldram MM, Bae S, Locke JE, Reed RD, Lentine KL, Gupta G, Weir MR, Friedewald JJ, Verbesey J, Cooper M, Segev DL, Massie AB.
    Clin J Am Soc Nephrol; 2019 Oct 07; 14(10):1493-1499. PubMed ID: 31537534
    [Abstract] [Full Text] [Related]

  • 13. End-stage renal disease after kidney donation: a single-center experience.
    Rosenblatt GS, Nakamura N, Barry JM.
    Transplant Proc; 2008 Jun 07; 40(5):1315-8. PubMed ID: 18589095
    [Abstract] [Full Text] [Related]

  • 14. Long-term risks of kidney living donation: review and position paper by the ERA-EDTA DESCARTES working group.
    Maggiore U, Budde K, Heemann U, Hilbrands L, Oberbauer R, Oniscu GC, Pascual J, Schwartz Sorensen S, Viklicky O, Abramowicz D, ERA-EDTA DESCARTES working group.
    Nephrol Dial Transplant; 2017 Feb 01; 32(2):216-223. PubMed ID: 28186535
    [Abstract] [Full Text] [Related]

  • 15. Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate.
    Grams ME, Sang Y, Levey AS, Matsushita K, Ballew S, Chang AR, Chow EK, Kasiske BL, Kovesdy CP, Nadkarni GN, Shalev V, Segev DL, Coresh J, Lentine KL, Garg AX, Chronic Kidney Disease Prognosis Consortium.
    N Engl J Med; 2016 Feb 04; 374(5):411-21. PubMed ID: 26544982
    [Abstract] [Full Text] [Related]

  • 16. Long-term Safety of Living Kidney Donation in an Emerging Economy.
    Rizvi SA, Zafar MN, Jawad F, Aziz T, Hussain Z, Hashmi A, Hussain M, Akhtar F, Ahmed E, Naqvi R, Naqvi SA.
    Transplantation; 2016 Jun 04; 100(6):1284-93. PubMed ID: 26854790
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Causes and timing of end-stage renal disease after living kidney donation.
    Matas AJ, Berglund DM, Vock DM, Ibrahim HN.
    Am J Transplant; 2018 May 04; 18(5):1140-1150. PubMed ID: 29369517
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.